Articles On Dongfang Modern Agriculture Holding Group (ASX:DFM)
Title | Source | Codes | Date |
---|---|---|---|
There are still some Chinese stocks left on the ASX; here are 3 that are up over 100pc in 12 months
Recent years haven’t been a good time for investors in many Chinese domiciled ASX stocks, although a handful have managed to perform. The middle of last decade saw a flurry of listings from China, many of which ended up delisted due to boar... |
Stockhead | DFM | 3 years ago |
Hong Kong domiciled penny stock Merchant House nearly triples after US$20m factory sale
Shares in microcap stock Merchant House (ASX:MHI) nearly tripled after a US$20 million asset sale. The Hong Kong domiciled company has textile and footwear factories in the USA and China. While textiles in China was a good market for Mercha... |
Stockhead | DFM | 3 years ago |
The Secret Broker: Bring out ‘yer dead
After 35 years of stockbroking for some of the biggest houses and investors in Australia and the UK, the Secret Broker is regaling Stockhead readers with his colourful war stories — from the trading floor to the dealer’s desk. All ASX-liste... |
Stockhead | DFM | 4 years ago |
The most noteworthy directors trades of 2019
Every week Stockhead publishes a weekly column of directors trades of $100,000 or more among ASX small caps. As 2019 draws to a close, we thought we could re-cap the most noteworthy trades. Biggest trade Wagners (ASX:WGN) co-founders Deni... |
Stockhead | DFM | 4 years ago |
Dongfang Modern Agriculture’s directors jump ship in mass exodus
After a “please explain” from the ASX, Chinese agricultural producer Dongfang Modern Agriculture (ASX: DFM) has released a statement attempting to clarify why four directors, the chief executive officer and company secretary all jumped ship... |
SmallCaps | DFM | 5 years ago |
Corporate: Cynata Therapeutics confirms it has a takeover suitor
Stem cell manufacturer Cynata Therapeutics (ASX: CYP) has announced this morning it has received an acquisition proposal. Japanese pharmaceutical company Sumitomo Dainippon Pharma has proposed to acquire the company for $2 per share (which... |
Stockhead | DFM | 5 years ago |
Director’s Trades: Everyone’s on holidays except those dreaming of one
This week only six directors traded $100,000 or more. So we’ve also recapped some big directors’ trades from earlier this year seeing if they paid off – including that millennial director who spent $100,000 on his company rather than a hous... |
Stockhead | DFM | 5 years ago |
Investment activity steps up with June numbers proving solid for the ASX
The ASX released its monthly report this morning and June was a strong month to cap off the financial year. Investors took to the market in droves, making 32.4 million trades – over 8 million more than June 2018. In the last 12 months they... |
Stockhead | DFM | 5 years ago |